Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function

Journal of Nutritional Biochemistry

Volumn 23, Issue 12, 2012, Pages 1676-1684

  Valdecantos, M Pilar ^a   Pérez Matute, Patricia ^a,b   González Muniesa, Pedro ^a   Prieto Hontoria, Pedro L ^a   Moreno Aliaga, María J ^a   Martínez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

Author keywords

Energy efficiency; Energy homeostasis; High fat diet; Insulin resistance; Mitochondrial dysfunction; Obesity; Oxidative phosphorylation; Steatosis; Triglyceride synthesis

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRIC ACID; LIVER ENZYME; THIOCTIC ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON TRANSPORT; ENZYME BLOOD LEVEL; FATTY ACID OXIDATION; GENE; GENE DOSAGE; GENE EXPRESSION; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIVER INJURY; LIVER PROTECTION; LIVER WEIGHT; MALE; MITOCHONDRION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OXIDATIVE PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; UCP2 GENE; WHITE ADIPOSE TISSUE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CITRIC ACID CYCLE; DIET, HIGH-FAT; ENZYMES; FATTY LIVER; GENE EXPRESSION REGULATION; INSULIN; ION CHANNELS; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MITOCHONDRIA, LIVER; MITOCHONDRIAL PROTEINS; ORGAN SIZE; PHOSPHORYLATION; PROTECTIVE AGENTS; RATS; RATS, WISTAR; THIOCTIC ACID; TRANSAMINASES; TRIGLYCERIDES;

RATTUS; RATTUS NORVEGICUS;

EID: 84869097147     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.11.011     Document Type: Article

References (64)

1. Burt A.D., Mutton A., Day C.P. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998, 15:246-258.
2. Carmiel-Haggai M., Cederbaum A.I., Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. Faseb J 2005, 19:136-138.
3. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183-1192.
4. Perez-Carreras M., Del Hoyo P., Martin M.A., Rubio J.C., Martin A., Castellano G., et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003, 38:999-1007.
5. Rector R.S., Thyfault J.P., Uptergrove G.M., Morris E.M., Naples S.P., Borengasser S.J., et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 2010, 52:727-736.
6. Pessayre D., Berson A., Fromenty B., Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001, 21:57-69.
7. Robertson G., Leclercq I., Farrell G.C. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol 2001, 281:G1135-1139.
8. Raffaella C., Francesca B., Italia F., Marina P., Giovanna L., Susanna I. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity (Silver Spring) 2008, 16:958-964.
9. Mollica M.P., Lionetti L., Moreno M., Lombardi A., De Lange P., Antonelli A., et al. 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. J Hepatol 2009, 51:363-370.
10. Padmalayam I., Hasham S., Saxena U., Pillarisetti S. Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance. Diabetes 2009, 58:600-608.
11. Reed L.J. From lipoic acid to multi-enzyme complexes. Protein Sci 1998, 7:220-224.
12. Maritim A.C., Sanders R.A., Watkins J.B. Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 2003, 14:288-294.
13. McCarty M.F., Barroso-Aranda J., Contreras F. The "rejuvenatory" impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-gamma coactivator-1alpha. Med Hypotheses 2009, 72:29-33.
14. Sadi G., Yilmaz O., Guray T. Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase. Mol Cell Biochem 2008, 309:109-116.
15. Wollin S.D., Wang Y., Kubow S., Jones P.J. Effects of a medium chain triglyceride oil mixture and alpha-lipoic acid diet on body composition, antioxidant status, and plasma lipid levels in the Golden Syrian hamster. J Nutr Biochem 2004, 15:402-410.
16. Prieto-Hontoria P.L., Perez-Matute P., Fernandez-Galilea M., Barber A., Martinez J.A., Moreno-Aliaga M.J. Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport. J Physiol Biochem 2009, 65:43-50.
17. Timmers S., de Vogel-van den Bosch J., Towler M.C., Schaart G., Moonen-Kornips E., Mensink R.P., et al. Prevention of high-fat diet-induced muscular lipid accumulation in rats by alpha lipoic acid is not mediated by AMPK activation. J Lipid Res 2010, 51:352-359.
18. Yang R.L., Li W., Shi Y.H., Le G.W. Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis. Nutrition 2008, 24:582-588.
19. Park K.G., Min A.K., Koh E.H., Kim H.S., Kim M.O., Park H.S., et al. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008, 48:1477-1486.
20. Rickwood D., Darley-Usmar V.M., Wilson M.T. Mitochondria a practical approach 1987, 1-16. IRL Press Oxford. V.M. Darley-Usmar, D. Rickwood, M.T. Wilson (Eds.).
21. Valdecantos M.P., Perez-Matute P., Quintero P., Martinez J.A. Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different. Redox Rep 2010, 15:207-216.
22. Perez-Matute P., Marti A., Martinez J.A., Fernandez-Otero M.P., Stanhope K.L., Havel P.J., et al. Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes. Mol Cell Endocrinol 2007, 268:50-58.
23. Perez-Echarri N., Perez-Matute P., Marcos-Gomez B., Marti A., Martinez J.A. Moreno-Aliaga MJ. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats. J Nutr Biochem 2009, 20:705-714.
24. Perez-Matute P., Neville M.J., Tan G.D., Frayn K.N., Karpe F. Transcriptional control of human adipose tissue blood flow. Obesity (Silver Spring) 2009, 17:681-688.
25. Aleardi A.M., Benard G., Augereau O., Malgat M., Talbot J.C., Mazat J.P., et al. Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr 2005, 37:207-225.
26. Benard G., Faustin B., Passerieux E., Galinier A., Rocher C., Bellance N., et al. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 2006, 291:1172-1182.
27. Terni B., Boada J., Portero-Otin M., Pamplona R., Ferrer I. Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology. Brain Pathol 2008, 20:222-233.
28. Liu H., Liu L., Liu K., Bizargity P., Hancock W.W., Visner G.A. Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression. J Immunol 2009, 183:1022-1031.
29. Lemasters J.J., Hackenbrock C.R. Continuous measurement and rapid kinetics of ATP synthesis in rat liver mitochondria, mitoplasts and inner membrane vesicles determined by firefly-luciferase luminescence. Eur J Biochem 1976, 67:1-10.
30. Dorta D.J., Pigoso A.A., Mingatto F.E., Rodrigues T., Prado I.M., Helena A.F., et al. The interaction of flavonoids with mitochondria: effects on energetic processes. Chem Biol Interact 2005, 152:67-78.
31. Yu X.X., Murray S.F., Pandey S.K., Booten S.L., Bao D., Song X.Z., et al. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 2005, 42:362-371.
32. Millar J.S., Stone S.J., Tietge U.J., Tow B., Billheimer J.T., Wong J.S., et al. Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. J Lipid Res 2006, 47:2297-2305.
33. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004, 114:147-152.
34. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
35. Zhang D., Liu Z.X., Choi C.S., Tian L., Kibbey R., Dong J., et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci USA 2007, 104:17075-17080.
36. Mandard S., Muller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 2004, 61:393-416.
37. Reddy J.K., Rao M.S. ipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol 2006, 290:852-858.
38. Butler J.A., Hagen T.M., Moreau R. Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys 2009, 485:63-71.
39. Sonoda J., Mehl I.R., Chong L.W., Nofsinger R.R., Evans R.M. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci USA 2007, 104:5223-5228.
40. Meirhaeghe A., Crowley V., Lenaghan C., Lelliott C., Green K., Stewart A., et al. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J 2003, 373:155-165.
41. Day C.P. NASH-related liver failure: one hit too many?. Am J Gastroenterol 2002, 97:1872-1874.
42. de Oliveira A.M., Rondo P.H., Luzia L.A., D'Abronzo F.H., Illison V.K. The effects of lipoic acid and alpha-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Diabetes Res Clin Pract 2011, 92:253-260.
43. Henriksen E.J., Diamond-Stanic M.K., Marchionne E.M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 2011, 51:993-999.
44. Poh Z.X., Goh K.P. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets 2009, 9:392-398.
45. Lin J., Tarr P.T., Yang R., Rhee J., Puigserver P., Newgard C.B., et al. PGC-1beta in the regulation of hepatic glucose and energy metabolism. J Biol Chem 2003, 278:30843-30848.
46. Hernandez C., Lin J.D. A sweet path to insulin resistance through PGC-1beta. Cell Metabolism 2009, 9:215-216.
47. Day C.P. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002, 16:663-678.
48. Sudheesh N.P., Ajith T.A., Janardhanan K.K., Krishnan C.V. Palladium alpha-lipoic acid complex formulation enhances activities of Krebs cycle dehydrogenases and respiratory complexes I-IV in the heart of aged rats. Food Chem Toxicol 2009, 47:2124-2128.
49. Sudheesh N.P., Ajith T.A., Janardhanan K.K., Krishnan C.V. Effect of POLY-MVA, a palladium alpha-lipoic acid complex formulation against declined mitochondrial antioxidant status in the myocardium of aged rats. Food Chem Toxicol 2010, 48:1858-1862.
50. Luz J., Zemdegs J.C., Amaral L.S. Chronic lipoic acid treatment worsens energy imbalances in streptozotocin-induced diabetic rats. Diabetes Metab 2009, 35:137-142.
51. Dlaskova A., Clarke K.J., Porter R.K. The role of UCP 1 in production of reactive oxygen species by mitochondria isolated from brown adipose tissue. Biochim Biophys Acta 2010, 1797:1470-1476.
52. Ricquier D. Respiration uncoupling and metabolism in the control of energy expenditure. Proc Nutr Soc 2005, 64:47-52.
53. Margareto J., Larrarte E., Marti A., Martinez J.A. Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARgamma and aP2 genes in adipose tissue: possible features of the antiobesity effects of a beta3-adrenergic agonist. Biochem Pharmacol 2001, 61:1471-1478.
54. Pecqueur C., Alves-Guerra M.C., Gelly C., Levi-Meyrueis C., Couplan E., Collins S., et al. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 2001, 276:8705-8712.
55. Rodgers J.T., Lerin C., Gerhart-Hines Z., Puigserver P. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett 2008, 582:46-53.
56. Wu Z., Boss O. Targeting PGC-1 alpha to control energy homeostasis. Expert Opin Ther Targets 2007, 11:1329-1338.
57. Finck B.N., Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006, 116:615-622.
58. Wang Y., Li X., Guo Y., Chan L., Guan X. alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism 2010, 59:967-976.
59. Shao D., Liu Y., Liu X., Zhu L., Cui Y., Cui A., et al. PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERR alpha. Mitochondrion 2010, 10:516-527.
60. Vianna C.R., Huntgeburth M., Coppari R., Choi C.S., Lin J., Krauss S., et al. Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance. Cell Metab 2006, 4:453-464.
61. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004, 10:727-733.
62. Kim M.S., Lee K.U. Role of hypothalamic 5'-AMP-activated protein kinase in the regulation of food intake and energy homeostasis. J Mol Med 2005, 83:514-520.
63. Min A.K., Kim M.K., Seo H.Y., et al. alpha-Lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway. Biochem Biophys Res Commun 2010, 393:536-541.
64. Foo N.P., Lin S.H., Lee Y.H., Wu M.J., Wang Y.J. alpha-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-beta. Toxicology 2011, 282:39-46.